View in EDS HTML Full Text PDF Full Text

Novel increasing dose regimen of tolvaptan for autosomal dominant polycystic kidney disease in patient with low tolerability.

Saved in:
Bibliographic Details
Title: Novel increasing dose regimen of tolvaptan for autosomal dominant polycystic kidney disease in patient with low tolerability.
Authors: Nakatani S; Department of Metabolism, Endocrinology, and Molecular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan., Ishimura E; Department of Nephrology, Osaka City University Graduate School of Medicine, Osaka, Japan., Machiba Y; Department of Metabolism, Endocrinology, and Molecular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan., Nakatani A; Department of Metabolism, Endocrinology, and Molecular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan., Fujimoto K; Department of Metabolism, Endocrinology, and Molecular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan., Uedono H; Department of Metabolism, Endocrinology, and Molecular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan., Okute Y; Department of Metabolism, Endocrinology, and Molecular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan., Tsuda A; Department of Metabolism, Endocrinology, and Molecular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan., Mori K; Department of Nephrology, Osaka City University Graduate School of Medicine, Osaka, Japan., Emoto M; Department of Metabolism, Endocrinology, and Molecular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan., Inaba M; Department of Metabolism, Endocrinology, and Molecular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.; Department of Nephrology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Source: Nephrology (Carlton, Vic.) [Nephrology (Carlton)] 2018 Aug; Vol. 23 (8), pp. 798-799.
Publication Type: Case Reports; Letter
Journal Info: Publisher: Blackwell Science Country of Publication: Australia NLM ID: 9615568 Publication Model: Print Cited Medium: Internet ISSN: 1440-1797 (Electronic) Linking ISSN: 13205358 NLM ISO Abbreviation: Nephrology (Carlton) Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 30920106
AccessLevel: 2
PubType: Report
PubTypeId: report
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Novel increasing dose regimen of tolvaptan for autosomal dominant polycystic kidney disease in patient with low tolerability.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Nakatani+S%22">Nakatani S</searchLink>; Department of Metabolism, Endocrinology, and Molecular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Ishimura+E%22">Ishimura E</searchLink>; Department of Nephrology, Osaka City University Graduate School of Medicine, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Machiba+Y%22">Machiba Y</searchLink>; Department of Metabolism, Endocrinology, and Molecular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Nakatani+A%22">Nakatani A</searchLink>; Department of Metabolism, Endocrinology, and Molecular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Fujimoto+K%22">Fujimoto K</searchLink>; Department of Metabolism, Endocrinology, and Molecular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Uedono+H%22">Uedono H</searchLink>; Department of Metabolism, Endocrinology, and Molecular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Okute+Y%22">Okute Y</searchLink>; Department of Metabolism, Endocrinology, and Molecular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Tsuda+A%22">Tsuda A</searchLink>; Department of Metabolism, Endocrinology, and Molecular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Mori+K%22">Mori K</searchLink>; Department of Nephrology, Osaka City University Graduate School of Medicine, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Emoto+M%22">Emoto M</searchLink>; Department of Metabolism, Endocrinology, and Molecular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Inaba+M%22">Inaba M</searchLink>; Department of Metabolism, Endocrinology, and Molecular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.; Department of Nephrology, Osaka City University Graduate School of Medicine, Osaka, Japan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229615568%22">Nephrology (Carlton, Vic.)</searchLink> [Nephrology (Carlton)] 2018 Aug; Vol. 23 (8), pp. 798-799.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Case Reports; Letter
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Blackwell+Science%22">Blackwell Science </searchLink><i>Country of Publication: </i>Australia <i>NLM ID: </i>9615568 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1440-1797 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213205358%22">13205358 </searchLink><i>NLM ISO Abbreviation: </i>Nephrology (Carlton) <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30920106
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/nep.13196
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 798
    Titles:
      – TitleFull: Novel increasing dose regimen of tolvaptan for autosomal dominant polycystic kidney disease in patient with low tolerability.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Nakatani S
      – PersonEntity:
          Name:
            NameFull: Ishimura E
      – PersonEntity:
          Name:
            NameFull: Machiba Y
      – PersonEntity:
          Name:
            NameFull: Nakatani A
      – PersonEntity:
          Name:
            NameFull: Fujimoto K
      – PersonEntity:
          Name:
            NameFull: Uedono H
      – PersonEntity:
          Name:
            NameFull: Okute Y
      – PersonEntity:
          Name:
            NameFull: Tsuda A
      – PersonEntity:
          Name:
            NameFull: Mori K
      – PersonEntity:
          Name:
            NameFull: Emoto M
      – PersonEntity:
          Name:
            NameFull: Inaba M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2018 Aug
              Type: published
              Y: 2018
          Identifiers:
            – Type: issn-electronic
              Value: 1440-1797
          Numbering:
            – Type: volume
              Value: 23
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Nephrology (Carlton, Vic.)
              Type: main
ResultId 1